MEDP

Medpace Holdings, Inc.

401.63 USD
-0.04 (-0.01%)
Last updated
This page is just a preview of the data found in TrendSpider’s full version

Medpace Holdings, Inc. stock is up 34.7% since 30 days ago. The next earnings date is Apr 22, 2024. The company has had above-average volume in the last 30 days. Its seasonality going into this month shows a chance of a red month, as 37.5% of the previous 7 February’s closed higher than January. In the last 10 Unusual Options Trades, there were 5 PUTs, 5 CALLs. 100% of analysts rate it a buy.

Options Flow Last 10
Date & Time Expiration Date Strike Price Trade Type Size Open Interest
20 Feb 15:11 15 Mar, 2024 400.00 PUT 21 203
20 Feb 15:11 15 Mar, 2024 390.00 PUT 22 121
20 Feb 15:11 15 Mar, 2024 400.00 PUT 40 203
20 Feb 15:11 15 Mar, 2024 400.00 PUT 97 203
21 Feb 19:48 15 Mar, 2024 320.00 CALL 10 179
21 Feb 20:40 15 Mar, 2024 390.00 PUT 26 321
22 Feb 16:47 20 Sep, 2024 450.00 CALL 10 2
23 Feb 14:39 15 Mar, 2024 300.00 CALL 5 1442
23 Feb 20:01 15 Mar, 2024 310.00 CALL 6 1427
23 Feb 20:01 15 Mar, 2024 300.00 CALL 6 1442

About Medpace Holdings, Inc.

Medpace Holdings, Inc. provides clinical research-based drug and medical device development services in North America, Europe, and Asia. It offers a suite of services supporting the clinical development process from Phase I to Phase IV in various therapeutic areas. The company was founded in 1992 and is based in Cincinnati, Ohio.

  • UBS
    Thu Feb 15, 05:22
    buy
    upgrade
  • Baird
    Wed Feb 14, 14:03
    buy
    confirm